# FDA Inspection 802162 - Bonfils Blood Center at Exempla Saint Joseph Hospital - October 03, 2012

Source: https://www.keypedia.com/records/fda_inspections/bonfils-blood-center-at-exempla-saint-joseph-hospital/79f2d37b-48e6-4d5f-a5de-e6844f0f6d2f
Source feed: FDA_Inspections

> FDA Inspection 802162 for Bonfils Blood Center at Exempla Saint Joseph Hospital on October 03, 2012. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 802162
- Company Name: Bonfils Blood Center at Exempla Saint Joseph Hospital
- Inspection Date: 2012-10-03
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 859561 - 2013-12-17](https://www.keypedia.com/records/fda_inspections/bonfils-blood-center-at-exempla-saint-joseph-hospital/4762f39e-bb0c-40eb-b389-7ff1c4b0a6e4)
- [FDA Inspection 786013 - 2012-06-11](https://www.keypedia.com/records/fda_inspections/bonfils-blood-center-at-exempla-saint-joseph-hospital/e4190e3d-8bd5-4746-b453-9434423b8131)

Company: https://www.keypedia.com/companies/bonfils-blood-center-at-exempla-saint-joseph-hospital/243b0370-81b5-425c-a2ae-1b8468bc4fc3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d